Tirzepatide

For Research Use Only
Not for Human Consumption · Not FDA Approved
These products are intended for in vitro research purposes only. They have not been evaluated by the Food and Drug Administration and are not intended to diagnose, treat, cure, or prevent any disease. Not for use in humans or animals.
This information is catalog education only. It is not medical advice, dosing guidance, a treatment plan, or an instruction to combine products.
What It Contains
- Tirzepatide research compound
- Dual GIP and GLP-1 receptor agonist research category
- Finished-product ingredients and excipients should be verified against the product label or COA before launch
Research Focus
- Weight-loss research: SURMOUNT program reporting up to 20.9% mean body weight reduction
- Glycemic control research showing superior HbA1c reductions compared to GLP-1 monotherapy
- Cardiovascular and metabolic marker research including blood pressure and lipid profiles
Research Pairings
- NAD+ for cellular energy and repair-signaling research context
- GHK-Cu for skin and tissue-remodeling research during body-composition studies
- Semaglutide only as a separate GLP-1 monotherapy comparison, not a combined-use recommendation


